Raloxifene D4

Raloxifene D4
Product Description

Deuterated Raloxifene, a nonsteroidal estrogen receptor mixed agonist/antagonist.;Labeled Raloxifene, intended for use as an internal standard for the quantification of Raloxifene by GC- or LC-mass spectrometry.

CLEARSYNTH LABS LIMITED

  • Country/Region:
    India
  • On CPHI since:
    2015
  • Certificates:
    2
  • Employees:
    250 - 499
Company types
CMO/CDMO
Manufacturer/Innovator
Primary activities
Agrochemical
Analytical Services
Biopharmaceutical
Clinical Research
Contract Manufacturer
Contract Research Organisation
Custom Manufacturing/Custom Synthesis
Fine Chemicals Company
Intermediates Manufacturer
Pharmacy
Specifications
  • CAS Registry Number
    1185076-44-1

CLEARSYNTH LABS LIMITED

  • Country/Region:
    India
  • On CPHI since:
    2015
  • Certificates:
    2
  • Employees:
    250 - 499
Company types
CMO/CDMO
Manufacturer/Innovator
Primary activities
Agrochemical
Analytical Services
Biopharmaceutical
Clinical Research
Contract Manufacturer
Contract Research Organisation
Custom Manufacturing/Custom Synthesis
Fine Chemicals Company
Intermediates Manufacturer
Pharmacy

More Products from CLEARSYNTH LABS LIMITED (99)

  • Rilpivirine D6

    Product Rilpivirine D6

    Labeled Rilpivirine, intended for use as an internal standard for the quantification of Rilpivirine by GC- or LC-mass spectrometry.
  • Sildenafil D3

    Product Sildenafil D3

    Labeled Sildenafil, intended for use as an internal standard for the quantification of Sildenafil by GC- or LC-mass spectrometry.
  • Sumatriptan

    Product Sumatriptan

    Molecular formula: C14H21N3O2SMolecular weight: 295.14
  • Dexlansoprazole

    Product Dexlansoprazole

    Molecular formula: C16H14F3N3O2SMolecular weight: 369.36
  • Diatrizoic acid

    Product Diatrizoic acid

    Molecular formula: C11H9I3N2O4Molecular weight: 613.91
  • Dipyridamole D20

    Product Dipyridamole D20

    Selective inhibitor of phosphodiesterase V (PDE 5); potent coronary vasodilator drug; adenosine transport inhibitor; inhibitor of platelet aggregation.;Labeled Dipyridamole, intended for use as an internal standard for the quantification of Dipyridamole by GC- or LC-mass spectrometry.
  • Ranolazine

    Product Ranolazine

    Ranolazine is an anti-ischemic agent which modulates myocardial metabolism. Antianginal.
  • 5-Hydroxy Propafenone Hydrochloride D5

    Product 5-Hydroxy Propafenone Hydrochloride D5

    Labeled Propafenone, intended for use as an internal standard for the quantification of Propafenone by GC- or LC-mass spectrometry.
  • Brimonidine

    Product Brimonidine

    a2-Adrenoceptor agonist. Antiglaucoma.
  • Cisplatin Impurity B

    Product Cisplatin Impurity B

    Potassium Trichloroammineplatinate is the degradation product of Cisplatin , an antitumor compound which exhibits mutagenic activity.;Impurity in commercial preparations of Cisplatin
  • Raloxifene Hydrochloride

    Product Raloxifene Hydrochloride

    A nonsteroidal, selective estrogen receptor modulator (SERM). Antiosteoporotic.
  • Tolterodine D14 Hydrochloride

    Product Tolterodine D14 Hydrochloride

    Labeled Tolterodine, intended for use as an internal standard for the quantification of Tolterodine by GC- or LC-mass spectrometry.

CLEARSYNTH LABS LIMITED resources (1)

  • Video Clearsynth Intro Video

    Clearsynth Labs Limited is a technology-based, research-driven, innovation-led enterprise specializing in deuterium chemistry and stable isotopes. Headquartered in Mumbai, with an R&D center in Hyderabad and a CDMO facility in Karnataka, alongside operations in Canada and the USA, we deliver solutions from milligram-scale R&D to multi-ton manufacturing. Our expertise spans deuterated APIs, intermediates, impurities, and reference standards. Backed by strong IP and 350+ scientists, we partner with innovators and generics across CDMO and CMO segments, committed to precision, quality, and advancing next-generation isotopic solutions for global pharmaceutical needs.